Spain· ES:60326

PULMOZYME 2.500 U/2,5 ml SOLUCIÓN PARA INHALACIÓN POR NEBULIZADOR

A medicinal product containing dornasa alfa, registered in Spain by Roche Farma S.A..

Checked against AEMPS CIMA (Spain) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about dornasa alfaAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

AEMPS CIMA (Spain)

Active substance: dornasa alfa
Manufacturer: Roche Farma S.A.
Country: Spain (ES)
ATC code: —
Reimbursed: Not published by this register
Source register: AEMPS CIMA (Spain)
Last checked: September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dornasa alfa in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dornasa alfa products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Pulmozyme
Belgium · Pulmozyme
Bulgaria · Пулмозим
Cyprus · Pulmozyme
Czechia · Pulmozyme
Germany · Pulmozyme
Denmark · Pulmozyme
Estonia · Pulmozyme
Finland · Pulmozyme
France · Pulmozyme
United Kingdom (Northern Ireland) · Pulmozyme
Greece · Pulmozyme
Croatia · Pulmozyme Otopina Za Atomizator
Hungary · Pulmozyme
Ireland · Pulmozyme
Iceland · Pulmozyme
Italy · Pulmozyme
Lithuania · Pulmozyme
Luxembourg · Pulmozyme
Latvia · Pulmozyme
Netherlands · Pulmozyme Verneveloplossing
Norway · Pulmozyme
Poland · Pulmozyme
Portugal · Pulmozyme
Romania · Pulmozyme
Sweden · Pulmozyme
Slovenia · Pulmozyme
Slovakia · Pulmozyme

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/4bccebc1-4684-4d21-b6b2-4c4da0ce1455
GET /v1/drugs/4bccebc1-4684-4d21-b6b2-4c4da0ce1455?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Uso Hospitalario",
  "estado": "{\"aut\":767743200000}",
  "nregistro": "60326",
  "substance": "dornasa alfa"
}

API reference MCP server Plans

See everything about dornasa alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console